Analysis on pan-cancer samples from TCGA showed that KCNN4 overexpressed in tumors compared with normal tissues in most common cancers, including PRAD, LUAD, and SARC (Figure 1(a)). The gene discussed is KCNN4; the disease is prostate adenocarcinoma.